Literature DB >> 17294104

Mechanisms of the blockade of glutamate channel receptors: significance for structural and physiological investigations.

L G Magazanik1, D B Tikhonov, T B Tikhonova, N Ya Lukomskaya.   

Abstract

The mechanism of the blocking action of phenylcyclohexyl derivative IEM-1925 on ionotropic NMDA and AMPA glutamate receptors was studied. Experiments on isolated rat brain neurons (hippocampal pyramidal cells and striatal cholinergic interneurons) were performed using local voltage clamping in the "whole cell" configuration. In equilibrium conditions at a membrane potential of -80 mV, there was no selectivity in the action of IEM-1925 on the open channels of either type of glutamate receptor. However, data were obtained showing significant differences in the mechanisms of the blocking actions. Although IEM-1925 was unable to penetrate into closed channels of either receptor type, molecules were able to leave closed AMPA receptor channels but not closed NMDA receptor channels. In hyperpolarization, the departure of the blocker from open NMDA receptor channels was slowed, while departure from open and closed AMPA receptor channels was accelerated. The blocker thus appeared able to penetrate AMPA receptor channels to enter cells, the gating mechanism of these channels being located above the blocker binding site. The actions of IEM-1925 on NMDA and AMPA receptors were compared with its ability to suppress tremor in mice induced with s.c. doses of arecoline. The results indicated that both types of receptors have a role in producing tremor. The differences in the mechanisms of action on AMPA and NMDA receptors may explain the ambiguous nature of the effects of the glutamate channel blocker in experimental therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294104     DOI: 10.1007/s11055-007-0012-9

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  24 in total

Review 1.  Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability.

Authors:  M A Rogawski
Journal:  Amino Acids       Date:  2000       Impact factor: 3.520

2.  Determinants of trapping block of N-methyl-d-aspartate receptor channels.

Authors:  K V Bolshakov; V E Gmiro; D B Tikhonov; L G Magazanik
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

Review 4.  Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

Authors:  M A Rogawski
Journal:  Trends Pharmacol Sci       Date:  1993-09       Impact factor: 14.819

Review 5.  Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide.

Authors:  S A Lipton
Journal:  Trends Neurosci       Date:  1993-12       Impact factor: 13.837

6.  Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues.

Authors:  N Burnashev; A Villarroel; B Sakmann
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

7.  The open channel blocking drug, IEM-1460, reveals functionally distinct alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors in rat brain neurons.

Authors:  M V Samoilova; S L Buldakova; V S Vorobjev; I N Sharonova; L G Magazanik
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 8.  Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

Authors:  C G Parsons; W Danysz; G Quack
Journal:  Neuropharmacology       Date:  1999-06       Impact factor: 5.250

9.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

10.  [Comparison of the anticonvulsant activity of organic mono- and di-cations and their potential to inhibit NMDA and AMPA glutamate receptors].

Authors:  N Ia Lukomskaia; N I Rukoiatkina; L V Gorbunova; V E Gmiro; K V Bol'shakov; L G Magazanik
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.